Greykasell Wealth Strategies, Inc. Bristol Myers Squibb CO Transaction History
Greykasell Wealth Strategies, Inc.
- $209 Billion
- Q2 2025
A detailed history of Greykasell Wealth Strategies, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Greykasell Wealth Strategies, Inc. holds 1,749 shares of BMY stock, worth $79,492. This represents 0.04% of its overall portfolio holdings.
Number of Shares
1,749
Previous 1,912
8.53%
Holding current value
$79,492
Previous $117 Million
30.59%
% of portfolio
0.04%
Previous 0.06%
Shares
2 transactions
Others Institutions Holding BMY
# of Institutions
2,676Shares Held
1.64BCall Options Held
22.4MPut Options Held
25.4M-
Vanguard Group Inc Valley Forge, PA195MShares$8.86 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.21 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.91 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.7MShares$4.31 Billion0.17% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA70.8MShares$3.22 Billion0.59% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $96.6B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...